Evidence map›Paper›PMID 36346502›Full record

ArticleAnnals of nuclear medicine2022

Celebrating 80 years anniversary of radioiodine for use in thyroid cancer and perspectives for theranostics.

Barbara Hertz, Tadashi Watabe, Richard P Baum

Open access · bronzeAbstract readEditorial
PubMed Publisher
In one paragraph

Article in Annals of nuclear medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Recent advances in the development ofAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2024
    Review
  7. Production of [EJNMMI radiopharmacy and chemistry · 2024
    Article
  8. Review
  9. Atypical Appearance on Radioiodine Scintigraphy Due to Achalasia Cardia - A Potential Diagnostic Pitfall.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Barbara HertzDr. Saul Archives, Curator, 6 Buckthorne Lane, Greenwich, CT, USA.
Tadashi WatabeDepartment of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, Suita, Japan. watabe@tracer.med.osaka-u.ac.jp.ORCID http://orcid.org/0000-0001-8658-2395
Richard P BaumCURANOSTICUM Frankfurt-Wiesbaden, Wiesbaden, Germany.
The University of Osaka · JP

Funding

AMED JP22lk0201139
6 · The paper itself

Abstract

In 1942, eighty years ago, Dr. Hertz first conducted radioiodine (RAI) diagnosis and therapy for thyroid disorders followed later by the successful treatment of thyroid cancer patients using RAI. In 2022, memorial 80 years later, alpha emitter astatine (

Indexed as

Iodine RadioisotopesThyroid NeoplasmsAnniversaries and Special EventsClinical Trials, Phase I as TopicHumansMalePeptidesPrecision MedicineTumor MicroenvironmentIodine RadioisotopesPeptides

Identifiers

PMID36346502
OpenAlexW4308551331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.